154 related articles for article (PubMed ID: 17951945)
1. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
3. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
4. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
[TBL] [Abstract][Full Text] [Related]
5. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
6. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
Moreira AC; Gaspar A; Serra MA; Simões J; Lopes da Cruz J; Amaral TF
J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
[TBL] [Abstract][Full Text] [Related]
10. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
11. Pattern of lipid profile in patients on maintenance hemodialysis.
Maheshwari N; Ansari MR; Darshana MS; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2010 May; 21(3):565-70. PubMed ID: 20427895
[TBL] [Abstract][Full Text] [Related]
12. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
[TBL] [Abstract][Full Text] [Related]
14. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
15. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous omega-3 fatty acid infusion and hemodialysis on fatty acid composition of free fatty acids and phospholipids in patients with end-stage renal disease.
Madsen T; Christensen JH; Toft E; Aardestrup I; Lundbye-Christensen S; Schmidt EB
JPEN J Parenter Enteral Nutr; 2011 Jan; 35(1):97-106. PubMed ID: 21224436
[TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
19. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
20. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):243-9. PubMed ID: 17586422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
